Our Mission:

Enhance health through pure, sustainable and science-based nutraceuticals.


Supercritical CO2 Extraction

Our Deep Extract™ supercritical CO2 extraction process enables us to manufacture key proprietary ingredients that are a part of clinically based natural solutions for prostate, joint and eye health and healthy aging.

  • Clean process
  • No chemical solvents
  • O2B® peroxidation technology for stability

Microalgae Manufacturing

Our state-of-the-art microalgae facilities are located in pristine environments, away from industrial and agricultural activities in Southern India and Chile.

We manufacture the best quality microalgae ingredients in the world, enabled by pure air, clean ground water, optimal sunlight and ideal temperature.

Integrated Supply Chain

Our GEMS Supply Chain Excellence Program operates on four value
pillars: Traceability, Sustainability, Purity, and Responsibility.

Valensa Enhance Health Since 1999


  • A study finding that FlexPro MD® reduces joint pain and inflammation is published in Nutrients, a peer reviewed scientific journal
  • Valensa awarded composition and method patent for joint pain relief using proprietary Hyaluronic Acid and Zanthin® Natural  Astaxanthin


  • Valensa became the first and only United States Pharmacopeia (USP) verified Saw Palmetto extract
  • USPlus® prostate health study showed a mechanism of action similar to leading European herbal medicine
  • Parry Organic Spirulina and Parry Organic Chlorella were recertified as Non-GMO
  • Valensa acquires 100% ownership of  Labelle Botanics farm operations in North Florida to control and stabilize the saw palmetto
    supply chain


  • USPlus® achieves “Fresh From Florida” recognition from Florida Department of Agriculture and Consumer Services
  • Clemson University finds significant effect for Valensa’s Zanthin® Natural Astaxanthin in a breast cancer cell model study
  • The GEMS Supply Chain Excellence Program is launched, formalizing Valensa’s focus on traceability, sustainability, purity and responsibility
  • Consistent with its commitment to  sustainability and responsibility Valensa champions institution of new Florida permit harvesting regulations to inhibit poaching on private and public lands


  • Valensa receives patents for Eye Pro® MD and Prostate® 360
  • Valensa introduces no cost analytical testing program to validate saw palmetto extract authenticity


  • Valesnsa achieves publication of down regulation of inflammation and joint health in an animal model of osteoarthritis using FlexPro® MD
  • 100% Organic Chlorella tablets launched in US


Valensa Awarded Major Use Patent for Omega-3 Composition and Women’s Health products launched:
  • Perilla Seed Extract formulated with Plant & Marine Omega-3s
  • Cran-Gyn® launched for UTI health


Valensa Patents Eye Health product: Eye Pro MD®
  • Offers an efficacious formula  clinically supported by the CARMIS study
  • Valensa launches formulation for regularity
Valensa/Parry acquires Astaxanthin Biomass Production facility
  • Chile-based Alimtec, to supply 100% of Valensa’s growth astaxanthin needs


Valensa’s FlexPro Products expand into in new channels
  • FlexPro MD® Out licensed to a major European Catalog Marketer
  • FlexPro MD® Out licensed to a major US Catalog Manufacturer
  • FlexPro ES® launched in collaboration with internet “Thought Leader”


Valensa leads the way in Cardiovascular, Eye, Neurological & Joint Care
  • Research showing Zanthin® Natural Astaxanthin’s ability to decrease oxidative stress and inflammation and enhanced immune response in humans published in the Journal of Nutrition & Metabolism
  • FlexPro MD® Joint health clinical trial successfully completed with 3 times better joint comfort than standard of care (Glucosamine Chondroitin)
  • FlexPro MD® Out licensed to one of the largest US Mass Market Retailer
  • Bio-available Astaxanthin + Perilla oil formulation out licensed to one of the leading marketers in the direct to consumer channel


Valensa develops unique Eye Care product based on CARMIS study
  • Eye Pro MD® launched
  • FlexPro MD® First joint health clinical trial (with astaxanthin-based formulation) initiated in the


Valensa forms Partnership with Parry Nutraceuticals
  • Parry Organic Spirulina added to product line
  • SpiruZan® launched (First product to combine Spirulina & Astaxanthin)
  • SpiruZan® Blue Coated launched (Spirulina + Astaxanthin tablet with Phycocyanin coating)
  • Science platform is created for cutting-edge multi-ingredient, condition specific, efficacious ingredients and formulations


Valensa Licenses Italian Research firm for Eye Health Clinical study
  • Zanthin® Natural Astaxanthin based formulation in the successful CARMIS study (Carotenoids and Antioxidants in Age-Related Maculopathy)
Valensa begins shelf-stable Chia extraction
  • Tresalbio® Omega-3 Chia Seed Extract launched
  • ChiaMax® functional food launched
  • Tresalbio quickly becomes the Omega-3 of choice for gummy applications


Parry Organic Spirulina becomes the first spirulina to achieve United States Pharmacopeia (USP) Dietary Ingredient Verification


Valensa develops O2B®Peroxidation Blocker technology
  •  State-of-the-art technology protects products from oxidation and rancidification


Valensa begins Deep Extract™ ultra-high pressure supercritical CO2 extraction of saw palmetto, astaxanthin and spices
  • Only facility of its kind in North America devoted exclusively to the production of premium nutraceutical ingredients and formulations
  • USPlus® Pure Lipidosterolic Extract – First dual patented product launched (solvent free)
Valensa becomes one of the nation’s top producers of astaxanthin
  • Valensa acquires LaHaye, one of the first astaxanthin pioneers
  • Tso Patent acquired for the use of astaxanthin in eye health management
  • Zanthin® Natural Astaxanthin launched for Eye Health and as


US Nutraceuticals (Valensa) founded in Eustis, Florida
  • Initiates supply chain and backward integration for processing Saw Palmetto
  • Incorporates state-of-the-art high pressure supercritical CO2 extraction technology

Valensa’s Vision

Valensa International is a leading science-based discoverer, developer and provider of high quality botanical sourced products for human health and well-being. We excel in the areas of nutraceutical supplements, functional foods, general nutrition, functional cosmetic ingredients and pharmaceutical formulations.

The core strengths of the company focus on creating the most advanced nature-based products in the markets we serve.

Our key technology platforms include extraction, formulation, delivery/biofunctionality, and product stabilization.

The company vigorously supports sustainable harvesting practices and manufacturing technologies that are environmentally sound.

Valensa believes that science-based creative ideas add real value for consumers, patients, employees and shareholders.

  • Science-based
  • Discovery & development
  • Botanical raw materials
  • Human health & well-being
  • High-tech, high-value products
  • Key technology platforms
  • Sustainability
  • Creativity adds value
This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data. (Link: https://www.floridablue.com/members/tools-resources/transparency)